pharma · Recurrent Pericarditis · Sjögren’s Disease · KNSA
Kiniksa Pharmaceuticals International
Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
100 Hayden Ave, Lexington, Massachusetts 02421, US HQ
2015 Founded
381 Employees
Public company Type
KNSA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Hayden Ave, Lexington, Massachusetts 02421, US
- Founded
- 2015
- Employees
- 381
- Programs
- 14
- Drugs
- 7
- Patents
- 9
Kiniksa Pharmaceuticals International projects
0 ClinicalTrials.gov programs sponsored by Kiniksa Pharmaceuticals International.
Kiniksa Pharmaceuticals International has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Kiniksa Pharmaceuticals International have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.